Douglas E. Linn

2.0k citations

17 papers · 1.5k indexed · 1 hit paper · h-index 11

Impact in

Pulmonary and Respiratory Medicine top 2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Cancer Research top 5%
- Cancer, Lipids, and Metabolism

Papers in ⓘ

Pulmonary and Respiratory Medicine 10
- Prostate Cancer Treatment and Research 10
Pathology and Forensic Medicine 5
- Cancer Mechanisms and Therapy 5

Co-authors: Yun Qiu (9 shared papers)Feng Sun (4 shared papers)Richeng Jiang (3 shared papers)Jonathan Melamed (4 shared papers)Hegang Chen (5 shared papers)Xi Yang (4 shared papers)Zhiyong Guo (4 shared papers)Xiangtian Kong (3 shared papers)
Journals: Cancer Research (5 papers)Journal of Biological Chemistry (2 papers)PLoS ONE (2 papers)Molecular Cancer Therapeutics (1 paper)Genes & Development (1 paper)
Partner nations: United States United Kingdom Canada

In The Last Decade

Douglas E. Linn

17 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth 2009 · 698 citations

Peers

Countries citing papers authored by Douglas E. Linn

Since Specialization

Citations

This map shows the geographic impact of Douglas E. Linn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Linn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Linn more than expected).

Fields of papers citing papers by Douglas E. Linn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. Linn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Linn. The network helps show where Douglas E. Linn may publish in the future.

Co-authors

The 25 scholars most cited alongside Douglas E. Linn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas E. Linn Line = papers co-authored together Douglas E. Linn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth Cancer Research ·Zhiyong Guo, Xi Yang, Feng Sun, Richeng Jiang, Douglas E. Linn, Hege Chen, Hegang Chen, Xiangtian Kong, Jonathan Melamed, Clifford G. Tepper, Hsing-Jien Kung, Angela Brodie, Joanne Edwards, Yun Qiu Hit paper breakdown →	2009	698
2	Regulation of Androgen Receptor Transcriptional Activity and Specificity by RNF6-Induced Ubiquitination Cancer Cell ·Kexin Xu, Hermela Shimelis, Douglas E. Linn, Richeng Jiang, Xi Yang, Feng Sun, Zhiyong Guo, Hege Chen, Wei Li, Hegang Chen, Xiangtian Kong, Jonathan Melamed, Shengyun Fang, Zhen Xiao, Timothy D. Veenstra, Yun Qiu	2009	183
3	ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients Genes & Development ·Esther Baena, Zhen Shao, Douglas E. Linn, Kimberly Glass, Melanie Hamblen, Yuko Fujiwara, Jonghwan Kim, Minh B. Nguyen, Xin Zhang, Frank J. Godinho, Roderick T. Bronson, Lorelei A. Mucci, Massimo Loda, Guo‐Cheng Yuan, Stuart H. Orkin, Zhe Li	2013	139
4	A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells Genes & Cancer ·Douglas E. Linn, Xi Yang, Feng Sun, Yuancai Xie, Huanwen Chen, Richeng Jiang, Saranya Chumsri, A. M. Burger, Yun Qiu	2010	83
5	Pim-1 Kinase Protects P-Glycoprotein from Degradation and Enables Its Glycosylation and Cell Surface Expression Molecular Pharmacology ·Yingqiu Xie, Mehmet Burcu, Douglas E. Linn, Yun Qiu, Maria R. Baer	2010	76
6	Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer Cell Reports ·João D. Barros‐Silva, Douglas E. Linn, Ivana Steiner, Guoji Guo, Adnan Ali, Hubert Pakula, Garry Ashton, Isabel Peset, Michael D. Brown, Noel W. Clarke, Roderick T. Bronson, Guo‐Cheng Yuan, Stuart H. Orkin, Zhe Li, Esther Baena	2018	64
7	Pim-1 Kinase Phosphorylates and Stabilizes 130 kDa FLT3 and Promotes Aberrant STAT5 Signaling in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication PLoS ONE ·Karthika Natarajan, Yingqiu Xie, Mehmet Burcu, Douglas E. Linn, Yun Qiu, Maria R. Baer	2013	59
8	Compensatory Upregulation of Tyrosine Kinase Etk/BMX in Response to Androgen Deprivation Promotes Castration-Resistant Growth of Prostate Cancer Cells Cancer Research ·Bojie Dai, Hege Chen, Shengjie Guo, Xi Yang, Douglas E. Linn, Feng Sun, Wei Li, Zhiyong Guo, Kexin Xu, Oekyung Kim, Xiangtian Kong, Jonathan Melamed, Shaopeng Qiu, Hegang Chen, Yun Qiu	2010	53
9	EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance Molecular Cancer Therapeutics ·Yuexing Zhang, Douglas E. Linn, Zhenqiu Liu, Jonathan Melamed, Fábio Távora, Charles Y.F. Young, Angelika M. Burger, Anne W. Hamburger	2008	51
10	Differential Regulation of Androgen Receptor by PIM-1 Kinases via Phosphorylation-dependent Recruitment of Distinct Ubiquitin E3 Ligases Journal of Biological Chemistry ·Douglas E. Linn, Xi Yang, Yingqiu Xie, Alan P. Alfano, Dhanraj Deshmukh, Xin Wang, Hermela Shimelis, Hegang Chen, Wěi Li, Kexin Xu, Ming‐Yuan Chen, Yun Qiu	2012	51
11	Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression Cancer Research ·Douglas E. Linn, Kathryn L. Penney, Roderick T. Bronson, Lorelei A. Mucci, Zhe Li	2016	27
12	A capillary electrophoresis based approach for the identification of anti-drug antibodies against camelid VHH biologics (Nanobodies®) Journal of Pharmacological and Toxicological Methods ·Derek Wiswell, Divas Neupane, Minchao Chen, Edward P. Bowman, Douglas E. Linn, Anandi Sawant, Alissa A. Chackerian, Shuli Zhang, Enrique Escandón	2020	8
13	The 44-kDa Pim-1 Kinase Phosphorylates BCRP/ABCG2 and Thereby Promotes Its Multimerization and Drug-resistant Activity in Human Prostate Cancer Cells Journal of Biological Chemistry ·Yingqiu Xie, Kexin Xu, Douglas E. Linn, (unknown), Zhiyong Guo, (unknown), Takeo Nakanishi, Douglas D. Ross, (unknown), (unknown), (unknown), Yun Qiu	2007	7
14	Genetic Interaction between Tmprss2-ERG Gene Fusion and Nkx3.1-Loss Does Not Enhance Prostate Tumorigenesis in Mouse Models PLoS ONE ·Douglas E. Linn, Roderick T. Bronson, Zhe Li	2015	5
15	Abstract 577: Antagonism of the co-inhibitory receptor BTLA enhances efficacy of anti-PD-1 treatment in murine syngeneic tumor models Cancer Research ·Nathan R. Miselis, Douglas E. Linn, Clifford R. Restaino, Toya Nath Baral, Jane Xia, Roanna Ueda, Anandi Sawant, Jeanne Baker, G. Raghunathan, Xinzhong Wang, Edward P. Bowman, Selvakumar Sukumar	2017	5
16	Abstract 4089: Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases. Cancer Research ·Douglas E. Linn, Xi Yang, Yingqiu Xie, Alan P. Alfano, Dhanraj Deshmukh, Xin Wang, Hermela Shimelis, Hegang Chen, Wěi Li, Kexin Xu, Ming‐Yuan Chen, Yun Qiu	2013	4
17	Protocols for Studies on TMPRSS2/ERG in Prostate Cancer Methods in molecular biology ·Hubert Pakula, Douglas E. Linn, Daniel R. Schmidt, Marit van Gorsel, Matthew G. Vander Heiden, Zhe Li	2018	1

About Douglas E. Linn

Douglas E. Linn is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Oncology, Hematology and Molecular Biology, having authored 17 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Cancer Mechanisms and Therapy (5 papers), Ubiquitin and proteasome pathways (4 papers), Peptidase Inhibition and Analysis (4 papers), Hormonal and reproductive studies (2 papers), Cancer-related gene regulation (2 papers), Estrogen and related hormone effects (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (953 citations), Cancer Research (379 citations), Endocrinology, Diabetes and Metabolism (249 citations), Molecular Biology (847 citations) and Oncology (334 citations). Douglas E. Linn has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Yun Qiu, Feng Sun, Richeng Jiang, Jonathan Melamed, Hegang Chen, Xi Yang, Zhiyong Guo, Xiangtian Kong, Hege Chen and Clifford G. Tepper. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, PLoS ONE, Molecular Cancer Therapeutics and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact